title: Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.
abstract: In allogeneic transplantation, including the B6 anti-BALB.B settings, H60 and H4 are two representative dominant minor histocompatibility antigens that induce strong CD8 T-cell responses. With different distribution patterns, H60 expression is restricted to hematopoietic cells, whereas H4 is ubiquitously expressed. H60-specific CD8 T-cell response has been known to be dominant in most cases of B6 anti-BALB.B allo-responses, except in the case of skin transplantation. To understand the mechanism underlying the subdominance of H60 during allogeneic skin transplantation, we investigated the dynamics of the H60-specific CD8 T cells in B6 mice transplanted with allogeneic BALB.B tail skin. Unexpectedly, longitudinal bioluminescence imaging and flow cytometric analyses revealed that H60-specific CD8 T cells were not always subdominant to H4-specific cells but instead showed a brief dominance before the H4 response became predominant. H60-specific CD8 T cells could expand in the draining lymph node and migrate to the BALB.B allografts, indicating their active participation in the anti-BALB.B allo-response. Enhancing the frequencies of H60-reactive CD8 T cells prior to skin transplantation reversed the immune hierarchy between H60 and H4. Additionally, H60 became predominant when antigen presentation was limited to the direct pathway. However, when antigen presentation was restricted to the indirect pathway, the expansion of H60-specific CD8 T cells was limited, whereas H4-specific CD8 T cells expanded significantly, suggesting that the temporary immunodominance and eventual subdominance of H60 could be due to their reliance on the direct antigen presentation pathway. These results enhance our understanding of the immunodominance phenomenon following allogeneic tissue transplantation.
authors: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
authors: Kang Il
authors: KI
authors: Yoo
authors: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
authors: Ji Yeong
authors: JY
authors: Jeon
authors: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
authors: Su Jeong
authors: SJ
authors: Ryu
authors: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
authors: Giri
authors: G
authors: Nam
authors: 1] Department of Nuclear Medicine, Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea [2] Tumor Microenvironment Global Core Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
authors: Hyewon
authors: H
authors: Youn
authors: Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
authors: Eun Young
authors: EY
authors: Choi
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D007371:Interferon-gamma; D008213:Lymphocyte Activation / Q000276:immunology; D018655:Lymphocyte Count; D051379:Mice; D015778:Minor Histocompatibility Antigens / Q000276:immunology* / Q000378:metabolism; D016038:Skin Transplantation; D014184:Transplantation, Homologous
chemical_list: D018984:Epitopes, T-Lymphocyte; D015778:Minor Histocompatibility Antigens; C114735:minor H antigen H60; D007371:Interferon-gamma